Journal
PERSONALIZED MEDICINE
Volume 14, Issue 5, Pages 389-400Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/pme-2017-0036
Keywords
clinical implementation; clinical utility; personalized medicine; pharmacogenetics; pharmacogenomics; pharmacogenomic testing; primary care physicians; qualitative research
Categories
Ask authors/readers for more resources
To explore primary care physicians' views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system. Methods: This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews. Results: Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs. Conclusion: While providers in this study viewed benefits of PGx testing as avoiding side effects, titrating doses more quickly, improving shared decision-making and providing psychological reassurance, challenges will need to be addressed such as privacy concerns, cost, insurance coverage and understanding the complexity of PGx test results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available